Moderna raises its 2021 sales forecast for its COVID-19 shot by 4.3% to $19.2 billion.
Moderna raises its 2021 sales forecast for its COVID-19 shot by 4.3% to $19.2 billion
The comments come a day after the United States said it wouldsupport waiving intellectual property rights for COVID-19 vaccinesin order to help speed an end to the pandemic, paving the way for what could be months of negotiations to hammer out a specific waiver plan.
Moderna shares were off 7.5% after falling as much as nearly 12% earlier. Shares of other COVID-19 vaccine manufacturers like Pfizer Incorporated were also down on the patent news."While this is a negative headline," said Morgan Stanley analysts in a research note, there is no mechanism"to force management to teach other manufacturers how to make their vaccine, suggesting no change to the status quo."
Moderna, which said in October it would not enforce patents on its vaccine during the pandemic, noted the lack of companies able to rapidly scale up complex manufacturing of a similar vaccine to meet surging global demand."They will have to go run a clinical trial, get the data, get the product approved, and scale manufacturing. This does not happen in 6 or 12 or 18 months," Moderna chief executive Stephane Bancel said on a post-earnings conference call. headtopics.com
Moderna has faced its own hurdles scaling up production with some shortfalls in the manufacturing supply chain, which includes Swiss contract manufacturer Lonza Group, leading to delivery delays in Europe.Bancel said he has had to tell some countries,"we're very sorry. We have no more supply for you in 2021."
Still, the company said it expects to produce between 800 million and 1 billion doses this year.Moderna raised its 2021 sales forecast for its COVID-19 shot by 4.3% to $19.2 billion on Thursday, two days after Pfizerincreased its full-year COVID-19 vaccine sales forecast
more than 70% to $26 billion.Moderna expects vaccine output could increase to 3 billion doses in 2022 to meet demand from nations looking to stock up supplies and sign up deals for"booster" doses.Early clinical trial data released on Wednesday, May 5, showed that a third dose of either Moderna's current shot or an experimental new vaccine increases immunity against the more easily transmissible virus variants first found in Brazil and South Africa.
Moderna, which is seeking to expand authorization of its vaccine to children and adolescents, on Thursday said an initial analysis of a study in those aged 12 to 17 showed an efficacy rate of 96%.The company also reported its first-ever quarterly profit on sales of the vaccine. headtopics.com
The SMC Hub
Welcome to The SMC Hub, SMC's online store. In these uncertain times, we are bringing you a safer, more convenient way to order your well-loved and trusted San Miguel products that go beyond making life easier, better for everyone in many meaningful ways.
SM to open 3 new malls in 2021 despite COVID-19 strugglesSM Prime is keen on opening malls in Camarines Norte, Capiz, and Caloocan City.
FDA chief expects applications for market use of COVID-19 vaccines by late 2021FDA Director General Eric Domingo says that before a certificate of product registration is issued, a vaccine company must first complete the phase 3 trials.
Indemnification package for severe COVID-19 vaccine adverse events eyed this monthThe Philippine Health Insurance Corporation is targeting to release this month the indemnification package for vaccine recipients who suffer serious side effects or even die after a COVID-19 vaccination, PhilHealth Vice President for Corp. Affairs Shirley Domingo says.
12 Filipino seafarers from India positive for COVID-19 evacuated, quarantined in vesselAn all-Filipino crew onboard a vessel from India is receiving emergency medical help after more than half tested positive for COVID-19, including two seafarers who are in critical condition. With little as 100$ you get 1000$ instant withdrawal no extra charges no referrer Send A Message Now 📩📩📩 We Work Round the clock ⏰ Just Click on the Link ✅ 👇👇👇👇👇👇
COVID-19 spreading in rural India; record daily rises in infections, deathsBENGALURU — India reported a record 412,262 new COVID-19 cases on Thursday and a record 3,980 daily death toll, as a second wave of infections swamps the health system and spreads from cities